These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11835884)

  • 1. [Clinical and therapeutic significance of hepatitis B virus heterogeneity].
    Campos RH; López JL
    Rev Clin Esp; 2001 Dec; 201(12):713-4. PubMed ID: 11835884
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B envelope protein mutants.
    McNair AN; Viaggi P; Smith HM; Tibbs CJ; Naoumov NV; Williams R
    Lancet; 1995 Jul; 346(8970):318-9. PubMed ID: 7630278
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of emergence of hepatitis B virus escape variants: approaches to prevention.
    Thomas HC
    J Viral Hepat; 1998 Nov; 5 Suppl 2():31-6. PubMed ID: 9857358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
    Gerlich WH; Glebe D
    EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
    [No Abstract]   [Full Text] [Related]  

  • 6. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for global prevention of hepatitis B virus infection.
    Van Damme P; Zanetti AR; Shouval D; Van Herck K
    Adv Exp Med Biol; 2010; 659():175-88. PubMed ID: 20204764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Escape mutants of hepatitis B virus].
    Jaramillo CM; Navas MC
    Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HBs escape mutants--implication of neutralization escape and diagnostic escape].
    Okamoto H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():98-105. PubMed ID: 15453295
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance.
    Schirmer P; Winters M; Holodniy M
    J Clin Virol; 2011 Nov; 52(3):261-4. PubMed ID: 21840252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the way towards the eradication of chronic hepatitis B.
    Ren H
    J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
    [No Abstract]   [Full Text] [Related]  

  • 12. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus escape mutants induced by antiviral therapy.
    Sheldon J; Soriano V
    J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China.
    Liu SL; Dong Y; Zhang L; Li MW; Wo JE; Lu LW; Chen ZJ; Wang YZ; Ruan B
    Arch Virol; 2009; 154(3):437-43. PubMed ID: 19212700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns.
    Badur S; Lazizi Y; Ugurlu M; Perk Y; Ilter O; Aydinli K; Pillot J
    J Infect Dis; 1994 Mar; 169(3):704-6. PubMed ID: 8158060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
    Torii N; Hasegawa K; Oomori K; Shiratori K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?
    François G; Kew M; Van Damme P; Mphahlele MJ; Meheus A
    Vaccine; 2001 Jul; 19(28-29):3799-815. PubMed ID: 11427251
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hepatitis B virus mutants on efficacy of vaccination.
    Zuckerman AJ
    Lancet; 2000 Apr; 355(9213):1382-4. PubMed ID: 10791517
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.